ConductScience.org, home

Paper41379296

Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review.

Manoharan S and 1 other. Mol Divers, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review. Papers, record 41379296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41379296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review.
PubMed
Journal
Mol Divers
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Manoharan SSuryaahttps://orcid.org/0000-0002-9777-4242
2Perumal EEkambaramhttps://orcid.org/0000-0003-2159-8198

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
QuinazolinesMajor topic
Antineoplastic AgentsMajor topic
Humans
Structure-Activity Relationship
Animals

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
111-2536-319/2K23/1Council of Scientific and Industrial Research, IndiaPubMed
5/8-4/15/Env/2020-NCD-IIICMR ad hocPubMed
CRD/2024/000898ASEAN-India Collaborative R&D SchemePubMed
ANRF/IRG/2024/001655/LSANRF-IRG SchemePubMed
CMRG/3005/H3/2024/080CMRG SchemePubMed

Source PubMed

Download CSV of grants

References95

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127231098Synthesis and Anticonvulsant Activity of N-(Substituted)-1-methyl-2,4-dioxo-1,2-dihydroquinazoline-3(4H)-carboxamides.Arch Pharm (Weinheim)2016https://conductscience.org/library/papers/27231098PubMed
229648554Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity.Org Biomol Chem2018https://conductscience.org/library/papers/29648554PubMed
338995264An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013-2023).J Med Chem2024https://conductscience.org/library/papers/38995264PubMed
47592939Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization.J Biol Chem1995https://conductscience.org/library/papers/7592939PubMed
534934125Synthesis and multifaceted pharmacological activity of novel quinazoline NHE-1 inhibitors.Sci Rep2021https://conductscience.org/library/papers/34934125PubMed
635805035Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.Cancers (Basel)2022https://conductscience.org/library/papers/35805035PubMed
723583850Synthesis, anticonvulsant, antioxidant and binding interaction of novel N-substituted methylquinazoline-2,4(1H,3H)-dione derivatives to bovine serum albumin: a structure-activity relationship study.Spectrochim Acta A Mol Biomol Spectrosc2013https://conductscience.org/library/papers/23583850PubMed
829342416Identification of novel quinazolinedione derivatives as RORγt inverse agonist.Bioorg Med Chem2018https://conductscience.org/library/papers/29342416PubMed
936295082Guanidine Derivatives of Quinazoline-2,4(1H,3H)-Dione as NHE-1 Inhibitors and Anti-Inflammatory Agents.Life (Basel)2022https://conductscience.org/library/papers/36295082PubMed
106800533Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6800533PubMed
1124856180Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents.Bioorg Med Chem2014https://conductscience.org/library/papers/24856180PubMed
1217318184Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation.EMBO J2007https://conductscience.org/library/papers/17318184PubMed
1327750154Synthesis, anti-varicella-zoster virus and anti-cytomegalovirus activity of quinazoline-2,4-diones containing isoxazolidine and phosphonate substructures.Eur J Med Chem2017https://conductscience.org/library/papers/27750154PubMed
14221973886-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists.Bioorg Med Chem Lett2012https://conductscience.org/library/papers/22197388PubMed
157493607The 5-HT2 receptor antagonist, pelanserin, inhibits alpha 1-adrenoceptor-mediated vasoconstriction in vitro.Eur J Pharmacol1995https://conductscience.org/library/papers/7493607PubMed
1635682608Discovery of Novel 3-Hydroxyquinazoline-2,4(1H,3H)-Dione Derivatives: A Series of Metal Ion Chelators with Potent Anti-HCV Activities.Int J Mol Sci2022https://conductscience.org/library/papers/35682608PubMed
1730002297Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization.Molecules2018https://conductscience.org/library/papers/30002297PubMed
1832582763Novel Quinazolin-2,4-Dione Hybrid Molecules as Possible Inhibitors Against Malaria: Synthesis and in silico Molecular Docking Studies.Front Mol Biosci2020https://conductscience.org/library/papers/32582763PubMed
191080313Metabolism of 1-(3-trifluoromethylphenyl)-3-(2-hydroxyethyl) quinazoline-2,4(1H,3H)-dione (H-88). I. Species differences in metabolism.Xenobiotica1975https://conductscience.org/library/papers/1080313PubMed
2032510731Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors.Arch Pharm (Weinheim)2020https://conductscience.org/library/papers/32510731PubMed

See all 95 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42796451Synthesis of Quinazoline Derivatives and Mechanistic Approaches in Lung and Breast Cancers.Molecules2026https://conductscience.org/library/papers/42796451

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41379296

GET https://conductscience.org/api/papers/v1/41379296/references?page=2